These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 23730692)

  • 1. siRNA-based nanomedicine.
    Zhao J; Mi Y; Feng SS
    Nanomedicine (Lond); 2013 Jun; 8(6):859-62. PubMed ID: 23730692
    [No Abstract]   [Full Text] [Related]  

  • 2. Strategies and advances in nanomedicine for targeted siRNA delivery.
    Nimesh S; Gupta N; Chandra R
    Nanomedicine (Lond); 2011 Jun; 6(4):729-46. PubMed ID: 21718181
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Eighth International Nanomedicine and Drug Delivery Symposium (NanoDDS'10).
    Kabanov A; Bronich T
    J Control Release; 2011 Jul; 153(1):1. PubMed ID: 21645563
    [No Abstract]   [Full Text] [Related]  

  • 4. RNAi nanomedicines: challenges and opportunities within the immune system.
    Weinstein S; Peer D
    Nanotechnology; 2010 Jun; 21(23):232001. PubMed ID: 20463388
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nanostructured Hyaluronic Acid-based Materials for the Delivery of siRNA.
    Shah K; Chawla S; Gadeval A; Reddy G; Maheshwari R; Kalia K; Tekade RK
    Curr Pharm Des; 2018; 24(23):2678-2691. PubMed ID: 30084325
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multifunctional envelope-type nano device for controlled intracellular trafficking and selective targeting in vivo.
    Kajimoto K; Sato Y; Nakamura T; Yamada Y; Harashima H
    J Control Release; 2014 Sep; 190():593-606. PubMed ID: 24794902
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Safety profile of RNAi nanomedicines.
    Barros SA; Gollob JA
    Adv Drug Deliv Rev; 2012 Dec; 64(15):1730-7. PubMed ID: 22732527
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A review of the current status of siRNA nanomedicines in the treatment of cancer.
    Resnier P; Montier T; Mathieu V; Benoit JP; Passirani C
    Biomaterials; 2013 Sep; 34(27):6429-43. PubMed ID: 23727262
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recent progress in nanomaterials for nucleic acid delivery in cancer immunotherapy.
    Mei Y; Wang R; Jiang W; Bo Y; Zhang T; Yu J; Cheng M; Wu Y; Cheng J; Ma W
    Biomater Sci; 2019 Jun; 7(7):2640-2651. PubMed ID: 31090764
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multifunctional nanomedicine platform for cancer specific delivery of siRNA by superparamagnetic iron oxide nanoparticles-dendrimer complexes.
    Taratula O; Garbuzenko O; Savla R; Wang YA; He H; Minko T
    Curr Drug Deliv; 2011 Jan; 8(1):59-69. PubMed ID: 21034421
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nanotechnology-Based Strategies for siRNA Brain Delivery for Disease Therapy.
    Zheng M; Tao W; Zou Y; Farokhzad OC; Shi B
    Trends Biotechnol; 2018 May; 36(5):562-575. PubMed ID: 29422412
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nanomedicine in cancer treatment.
    Yih TC; Wei C
    Nanomedicine; 2005 Jun; 1(2):191-2. PubMed ID: 17292078
    [No Abstract]   [Full Text] [Related]  

  • 13. Nanomedicine for cancer: lipid-based nanostructures for drug delivery and monitoring.
    Namiki Y; Fuchigami T; Tada N; Kawamura R; Matsunuma S; Kitamoto Y; Nakagawa M
    Acc Chem Res; 2011 Oct; 44(10):1080-93. PubMed ID: 21786832
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nanomedicinal delivery approaches for therapeutic siRNA.
    Keller M
    Int J Pharm; 2009 Sep; 379(2):210-1. PubMed ID: 19716034
    [TBL] [Abstract][Full Text] [Related]  

  • 15. siRNA delivery systems for cancer treatment.
    Oh YK; Park TG
    Adv Drug Deliv Rev; 2009 Aug; 61(10):850-62. PubMed ID: 19422869
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Construction of negatively charged and environment-sensitive nanomedicine for tumor-targeted efficient siRNA delivery.
    Wang Y; Xiao H; Fang J; Yu X; Su Z; Cheng D; Shuai X
    Chem Commun (Camb); 2016 Jan; 52(6):1194-7. PubMed ID: 26603479
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeted nanoblobs spot treat cancer and heart disease.
    Wolfson W
    Chem Biol; 2006 Apr; 13(4):343-5. PubMed ID: 16632245
    [No Abstract]   [Full Text] [Related]  

  • 18. Therapeutic potential of RNA interference against cancer.
    Takeshita F; Ochiya T
    Cancer Sci; 2006 Aug; 97(8):689-96. PubMed ID: 16863503
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Harnessing the potential of lipid-based nanomedicines for type-specific ovarian cancer treatments.
    Leung AW; Kalra J; Santos ND; Bally MB; Anglesio MS
    Nanomedicine (Lond); 2014 Mar; 9(3):501-22. PubMed ID: 24746193
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Therapeutic targeting in the silent era: advances in non-viral siRNA delivery.
    Guo J; Fisher KA; Darcy R; Cryan JF; O'Driscoll C
    Mol Biosyst; 2010 Jul; 6(7):1143-61. PubMed ID: 20431817
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.